Cited by 52Diabetes Management and ResearchDiabetes Management and EducationDiabetes Treatment and Management

Are risk indices derived from CGM interchangeable with SMBG-Based indices?

Open access
Fabris, Chiara, Patek, Stephen D., Breton, Marc D.·2016·Journal of Diabetes Science and Technology

Abstract

BACKGROUND: The risk of hypo- and hyperglycemia has been assessed for years by computing the well-known low blood glucose index (LBGI) and high blood glucose index (HBGI) on sparse self-monitoring blood glucose (SMBG) readings. These metrics have been shown to be predictive of future glycemic events and clinically relevant cutoff values to classify the state of a patient have been defined, but their application to continuous glucose monitoring (CGM) profiles has not been validated yet. The aim of this article is to explore the relationship between CGM-based and SMBG-based LBGI/HBGI, and provide a guideline to follow when these indices are computed on CGM time series. METHODS: Twenty-eight subjects with type 1 diabetes mellitus (T1DM) were monitored in daily-life conditions for up to 4 weeks with both SMBG and CGM systems. Linear and nonlinear models were considered to describe the relationship between risk indices evaluated on SMBG and CGM data. RESULTS: LBGI values obtained from CGM did not match closely SMBG-based values, with clear underestimation especially in the low risk range, and a linear transformation performed best to match CGM-based LBGI to SMBG-based LBGI. For HBGI, a linear model with unitary slope and no intercept was reliable, suggesting that no correction is needed to compute this index from CGM time series. CONCLUSIONS: Alternate versions of LBGI and HBGI adapted to the characteristics of CGM signals have been proposed that enable extending results obtained for SMBG data and using clinically relevant cutoff values previously defined to promptly classify the glycemic condition of a patient.

Integrity signals

Registry

Crossref · 10.1177/1932296815599177

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The performance of the NN-based bolus calculator was assessed on an independent test set generated by the UVa/Padova T1D Simulator.

    “The performance of the NN-based BC was assessed on an independent test set generated by the UVa/Padova T1D Simulator in terms of blood glucose risk index (BGRI) [39], i.e., a popular metric of glycemic control that, thanks to symmetrisation of the glucose scale, is equally sensitive to hypoglycemia and hyperglycemia.”

The citation lists haven’t been fetched yet

References 16 · Cited by 52

Authors
Fabris, C., Patek, S. D., & Breton, M. D.
Affiliations
  • University of Padua (IT)
  • University of Virginia (US)
Corresponding author
Breton, Marc D.
Venue
Journal of Diabetes Science and Technology
Published
2015-08-14
Volume
10
Issue
1
Pages
50-59
ISSN
1932-2968 (ISSN-L)
OpenAlex
W2269003205
Cited by
52
References
16
Citations by year
2026: 4 · 2025: 2 · 2024: 4 · 2023: 2 · 2022: 3 · 2021: 8 · 2020: 9 · 2019: 8 · 2018: 6 · 2017: 4 · 2016: 2
FWCI
3.48
Type
journal article
Language
en
Open access
Locations
  • Journal of Diabetes Science and Technology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01dk051562-23)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK-051562)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
continuous glucose monitoring, self-monitoring of blood glucose, low blood glucose index, type 1 diabetes, hypoglycemia, hyperglycemia, linear operators
MeSH terms
Adult, Blood Glucose, Diabetes Mellitus, Type 1, Female, Humans, Insulin Infusion Systems, Male, Middle Aged, Risk, Blood Glucose Self-Monitoring, Infusion Pumps, Implantable

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review